Related Experiment Video
Updated: Sep 21, 2025

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy
Allison Kirchner1, Maureen Riegert1, Eden Lake1
1Ms. Kirchner is from the Department of Dermatology, University of Illinois College of Medicine, Chicago. Drs. Riegert and Lake are from the Division of Dermatology, Stritch School of Medicine, Loyola University, Chicago.
Abstract:
Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease of the skin that commonly affects women of childbearing age. Some of the medications used in the treatment of CLE are safe in pregnancy, whereas others are contraindicated based on their teratogenic effects. We describe the most recent recommendations for the use of commonly prescribed CLE medications for those who are pregnant or plan on becoming pregnant.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Nephrotic Syndrome III : Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Nephrotic Syndrome II : Assessment and Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

